Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Neptunus Group is a leading integrated healthcare conglomerate based in China, established in 1989. The company maintains a comprehensive presence across the pharmaceutical value chain, including research and development, manufacturing, logistics, and retail. It is widely recognized for its Neptunus Star pharmacy chain, which is one of the largest retail drug networks in the country. The group's product portfolio encompasses innovative biologics, modern Traditional Chinese Medicine, and high-end generic pharmaceuticals. With a strong emphasis on brand value and market reach, Neptunus Group continues to be a dominant force in the Chinese domestic healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Neptunus Group.